| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/12/2001 | US6245904 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific T-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245887 An isolated enzyme; for producing large quantities of c-terminal .alpha.-amidating enzyne |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245550 Nucleotide sequence from gene homologous to erythropoetin and growth hormone; diagnosis; therapy of blood disorders, developmental/growth defects, and obesity; anti-inflammatory, antidiabetic, anticarcinogenic agents |
| 06/12/2001 | US6245545 Culturing a cell transformed with the vector comprising the isolated dna encoding the endonuclease of staphloccus warneri; used to cleave dna molecules into fragments for molecular cloning and gene characterization |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245533 Nucleic acid-free thermostable enzymes and methods of production thereof |
| 06/12/2001 | US6245527 Nucleotide sequence which encodes preferential platelet receptors; for the diagnosis and treatment of atherosclerosis, cardiovascular disorders and tumor metastasis; antitumor agents |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245524 Phenylacetyl-CoA ligase from penicillium chrysogenum |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245504 Transducing phages of Actinomycetales |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245335 Choline binding proteins for anti-pneumococcal vaccines |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
| 06/12/2001 | US6245295 Sample testing apparatus with high oxygen permeable tape providing barrier for closed reaction chamber |
| 06/12/2001 | US6245235 Butane/oxygen injection system results in substantially improved treatment of contaminated sites. pollutants such as chlorinated aliphatic hydrocarbons |
| 06/12/2001 | CA2092717C Expression of g protein coupled receptors in yeast |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA2043953C Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant dna and transformed microorganisms |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/10/2001 | CA2326730A1 Novel nucleotide sequences coding for the genes sdha, sdhb and sdhc |
| 06/09/2001 | CA2325766A1 Novel nucleotide sequences coding for the zwa2 gene |
| 06/09/2001 | CA2325593A1 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
| 06/07/2001 | WO2001040518A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040489A1 Methods for producing a polypeptide using a consensus translational initiator sequence |
| 06/07/2001 | WO2001040478A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | WO2001040476A2 Bacillus thuringiensis toxin active against formicidae (ant) |
| 06/07/2001 | WO2001040475A2 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040453A1 Process and system for electrical extraction of intracellular matter from biological matter |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040450A1 Novel carbonyl reductase, gene thereof and method of using the same |
| 06/07/2001 | WO2001040441A2 Treatment of seeds and plants with useful bacteria |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040290A1 Immunogen, antivenom and vaccine against the venom of the black widow spider |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/07/2001 | WO2001039768A1 Process for recovering statin compounds from a fermentation broth |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001020005A8 Regulatory sequences and expression cassettes for yeasts, especially for kluyveromyces |
| 06/07/2001 | WO2001014520A3 Phage resistant lactic acid bacterial mutants |
| 06/07/2001 | WO2001011071A3 Bioproduction of para-hydroxycinnamic acid |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO1998055629A3 A soybean peroxidase gene family and an assay for detecting soybean peroxidase activity |
| 06/07/2001 | DE19958160A1 Neue für das gpm-Gen codierende Nukleotidsequenzen New coding for the gpm gene nucleotide sequences |
| 06/07/2001 | DE19958159A1 Neue für das glk-Gen codierende Nukleotidsequenzen New coding for the glk gene nucleotide sequences |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | DE10056338A1 Treatment of a medium, especially waste water, with microorganisms from bioreactor comprises controlling bioreactor in response to physical, chemical and/or biochemical parameter of medium |
| 06/07/2001 | CA2397731A1 Immunogen antivenom and vaccine against the venom of the black widow sp ider |
| 06/07/2001 | CA2396655A1 Treatment of seeds and/or plants with pseudomonas culture |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394142A1 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393360A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | CA2388538A1 Bacillus thuringiensis toxin active against formicidae (ant) |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/06/2001 | EP1104812A1 Nucleotide sequences coding for the gpm gene |
| 06/06/2001 | EP1104810A1 Method for the fermentative production of L-lysine using coryneform bacteria |
| 06/06/2001 | EP1104809A1 Process for producing alpha-interferon |
| 06/06/2001 | EP1104808A1 ESTs and encoded human proteins |
| 06/06/2001 | EP1104489A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids |
| 06/06/2001 | EP1104484A2 Composition and methods for exposing antigenic epitopes on cultured microorganisms |